Steroid-induced avascular necrosis (AVN) of the lower extremity is a destructive process of the bone found in patients who have been treated with these medications for a variety of medical conditions. There are several proposed etiologies for development of this condition, however much debate still remains for the exact pathophysiology. The main clinical characteristics include edema, arthralgias, and restricted joint range of motion. Diagnostic imaging is a key aspect in the analysis of this pathologic process. When steroid-induced AVN affects multiple bones, this atypical presentation is difficult to treat due to its diffuse nature, therefore surgical options are limited. In these cases, conservative therapy is targeted toward pain relief and preserving joint range of motion. This review aims to provide an overview on the presentation of steroid-induced AVN in the foot and ankle, outline the pathophysiology of the process, and describe a variety of both conservative and surgical treatment options. A case study is provided to showcase a patient presentation of diffuse steroid-induced AVN of the foot and ankle and their course of treatment.
NixonJE.Early diagnosis and treatment of steroid induced avascular necrosis of Bone. Br Med J (Clin Res Ed). 1984;288:741-744.
2.
ChanKLMokCC.Glucocorticoid-induced avascular bone necrosis: diagnosis and management. Open Orthop J. 2012;6:449-457.
3.
CouturierSGoldG.Imaging features of avascular necrosis of the foot and ankle. Foot Ankle Clin. 2019;24:17-33.
4.
HungerfordDSZizicTM.The treatment of ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore). 1980;59:143-148.
5.
LiuLHZhangQYSunWLiZRGaoFQ.Corticosteroid-induced osteonecrosis of the femoral head: detection, diagnosis, and treatment in earlier stages. Chin Med J (Engl). 2017;130:2601-2607.
6.
ShigemuraTNakamuraJKishidaS, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford). 2011;50:2023-2028.
7.
KwonHHBangSYWonS, et al. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus. Lupus. 2018;27:1644-1651.
8.
DeboisELCozenL.Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA. 1960;174:966-971.
9.
NakamuraJSaisuTYamashitaKSuzukiCKamegayaMTakahashiK.Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus. A prospective magnetic resonance imaging study. Arthritis Rheum. 2010;62:609-615.
10.
BergsteinJMWiensCFishAJVernierRLMichaelA.Avascular necrosis of bone in systemic lupus erythematosus. J Pediatr. 1974;85:31-35.
11.
NgoSTSteynFJMcCombePA.Gender differences in autoimmune diseases. Front Neuroendocrinol. 2014;35:347-369.
12.
KrennVMüllerSKrennVTHempflingH.Pathophysiology of aseptic femoral head necrosis: pathogenesis and histopathological differential diagnosis [in German]. Orthopade. 2018;47:710-716.
13.
BeltranJHermanLJBurkJM, et al. Femoral head avascular necrosis: MR imaging with clinical-pathologic and radionuclide correlation. Radiology. 1988;166(1pt 1):215-220.
14.
NarayananAKhanchandaniPBorkarRM, et al. Avascular necrosis of femoral head: a metabolomic, biophysical, biochemical, electron microscopic and histopathological characterization. Sci Rep. 2017;7:10721.
15.
FisherDE.The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental results. Clin Orthop Relat Res. 1978;(130):68-80.
16.
WangGJSweetDERegerSIThompsonRC.Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am. 1977;59:729-735.
17.
JonesJPJr.Intravascular coagulation and osteonecrosis. Clin Orthop Relat Res. 1992;(277):41-53.
18.
CruessRLRossDCrawshawE.The etiology of steroid-induced avascular necrosis of bone. A laboratory and clinical study. Clin Orthop Relat Res. 1975;(113):178-183.
19.
CalderJDFButteryLRevellPAPearseMPolakJM. Apoptosis—a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br. 2004;86:1209-1213.
20.
MontMAPivecRBanerjeeSIssaKElmallahRKJonesLC.High-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review. J Arthroplasty. 2015;30:1506-1512.e5.
21.
ChangCGreenspanAGershwinME.The pathogenesis, diagnosis, and clinical manifestations of steroid-induced osteonecrosis. J Autoimmunity. 2020;110:102460.
22.
PowellCChangCNaguwaSMCheemaGGershwinME.Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun Rev. 2010;9:721-743.
23.
FicatRP.Idiopathic bone necrosis of femoral head. Early diagnosis and treatment. J Bone Joint Surg Br. 1985;67:3-9.
24.
DhillonMSRanaBPandaIPatelSKumarP.Management options in avascular necrosis of talus. Indian J Orthop. 2018;52:284-296.
NeumayrLDAguilarCEarlesAN, et al; The National Osteonecrosis Trial in Sickle Cell Anemia Study Group. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am. 2006;88:2573-2582.
27.
MontMAHungerfordDS.Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459-474.
28.
ZhangQLiuLSunWGaoFChengLLiZ.Extracorporeal shockwave therapy in osteonecrosis of femoral head: a systematic review of now available clinical evidences. Medicine (Baltimore). 2017;96:e5897.
29.
YinTCWangCJYangKDWangFSSunYC.Shockwaves enhance the osteogenetic gene expression in marrow stromal cells from hips with osteonecrosis. Chang Gung Med J. 2011;34:367-374.
30.
GaoFSunWLiZ, et al. High-energy extracorporeal shock wave for early stage osteonecrosis of the femoral head: a single-center case series. Evid Based Complement Alternat Med. 2015;2015:468090.
31.
AljinovicJPivalicaDMarinovicI, et al. Hyperbaric oxygen therapy as a therapy option in the early phase of avascular necrosis of the femoral head. Int J Physiatry. 2016;2:010.
32.
CamporesiEMVezzaniGBoscoGMangarDBernasekTL.Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty. 2010;25(6 suppl):118-123.
33.
ReisNDSchwartzOMilitianuD, et al. Hyperbaric oxygen therapy as a treatment for stage-I avascular necrosis of the femoral head. J Bone Joint Surg Br. 2003;85:371-375.
34.
WangZZhouXXieL, et al. Acupotomy and acupuncture in the treatment of avascular necrosis of femoral head at the early and middle stages: a clinical randomized controlled trial [in Chinese]. Zhongguo Zhen Jiu. 2016;36:1031-1035.
35.
JafarianAAFarhoodiAMomeniMBabaeiMRKazemikhooN.Clinical and radiographic alterations in bilateral avascular necrosis of the femoral head following laser acupuncture: a case report. J Lasers Med Sci. 2018;9:149-153.
36.
AgarwalaSShahSB.Ten-year follow up of avascular necrosis of femoral head treated with alendronate for 3 years. J Arthroplasty. 2011;26:1128-1134.
37.
GuoPGaoFWangY, et al. The use of anticoagulants for prevention and treatment of osteonecrosis of the femoral head: a systematic review. Medicine (Baltimore). 2017;96:e6646.
38.
BeckmannRShaheenHKweiderN, et al. Enoxaparin prevents steroid-related avascular necrosis of the femoral head. ScientificWorldJournal. 2014;2014:347813.
39.
GlueckCJFreibergRASieveLWangP.Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;(435):164-170.
40.
IwakiriKOdaYKaneshiroY, et al. Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci. 2008;13:463-468.
41.
DrescherWBeckmannRKaschR, et al. Nitrate patch prevents steroid-related bone necrosis. J Orthop Res. 2011;29:1517-1520.
42.
ClaßenTBeckerALandgraeberS, et al. Long-term clinical results after iloprost treatment for bone marrow edema and avascular necrosis. Orthop Rev (Pavia). 2016;8:6150.
43.
PierceTPJaureguiJJElmallahRKLaverniaCLMontMANaceJ.A current review of core decompression in the treatment of osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8:228-232.
44.
PierceTPElmallahRKJaureguiJJPoolaSMontMADelanoisRE.A current review of non-vascularized bone grafting in osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8:240-245.
